HighTower Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HighTower Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,512	Closed	-$30K	–	3751
2022 Q4	$30K	Sell	35,512 -10,500	-23%	-$13.9K	﹤0.01%	3091
2022 Q3	$72K	Sell	46,012 -1,996	-4%	-$4.53K	﹤0.01%	2828
2022 Q2	$96K	Buy	48,008 +12,000	+33%	+$20.7K	﹤0.01%	2794
2022 Q1	$84K	Buy	36,008 +6,490	+22%	+$20.2K	﹤0.01%	3019
2021 Q4	$136K	Sell	29,518 -4,025	-12%	-$25K	﹤0.01%	2871
2021 Q3	$255K	Buy	33,543 +7,491	+29%	+$63.5K	﹤0.01%	2540
2021 Q2	$252K	Sell	26,052 -9,225	-26%	-$73.5K	﹤0.01%	2497
2021 Q1	$291K	Buy	35,277 +7,449	+27%	+$78.7K	﹤0.01%	2327
2020 Q4	$191K	Buy	27,828 +17,975	+182%	+$144K	﹤0.01%	2214
2020 Q3	$110K	Sell	9,853 -8,992	-48%	-$82.3K	﹤0.01%	2219
2020 Q2	$120K	Sell	18,845 -4,132	-18%	-$15.8K	﹤0.01%	2099
2020 Q1	$43K	Buy	22,977 +14,000	+156%	+$40.3K	﹤0.01%	2025
2019 Q4	$31K	Buy	+8,977	New	+$21.4K	﹤0.01%	2145
2018 Q2	–	Sell	-19,398	Closed	-$100K	–	2395
2018 Q1	$100K	Buy	+19,398	New	+$138K	﹤0.01%	1974
2017 Q2	–	Sell	-31,730	Closed	-$125K	–	2353
2017 Q1	$125K	Hold	31,730	–	–	﹤0.01%	1847
2016 Q4	$155K	Buy	31,730 +2,300	+8%	+$13.8K	﹤0.01%	1728
2016 Q3	$228K	Buy	+29,430	New	+$198K	﹤0.01%	1581

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

HighTower Advisors's SRNE Position: Q1 2023 in Review

HighTower Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 35,512 shares — an estimated $30K sold.

HighTower Advisors first reported a position in SRNE in Q3 2016 and held it in 17 quarters. The position peaked at $291K in Q1 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

HighTower Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
HighTower Advisors sold 35,512 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $30K.
HighTower Advisors first reported a position in Sorrento Therapeutics, Inc. in Q3 2016 and held it in 17 quarters.
HighTower Advisors's Sorrento Therapeutics, Inc. position peaked at $291K in Q1 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.